CN Stock MarketDetailed Quotes

605199 Hainan Huluwa Pharmaceutical Group

Watchlist

18.85
-1.53-7.51%

Trading Dec 9 11:18 CST

7.54BMarket Cap66.84P/E (TTM)

Hainan Huluwa Pharmaceutical Group Stock Forum

Moomoo AI

Feb 3 18:39

The company's high P/E ratio amid shrinking medium-term earnings is worrisome. The market's expected 42% growth next year highlights the company's recent earnings decline. The share price may drop further if business prospects don't significantly improve.

Hainan Huluwa Pharmaceutical Group Co., Ltd. (SHSE:605199) Shares May Have Slumped 25% But Getting In Cheap Is Still Unlikely

Moomoo AI

Jan 24 19:41

Despite a high rate of reinvestment, the low ROE suggests that this reinvestment is not benefiting its investors and is negatively impacting earnings growth. Caution is advised when dealing with this company.